Home/Filings/4/0001567619-19-018220
4//SEC Filing

Krainer Adrian R. 4

Accession 0001567619-19-018220

CIK 0001623526other

Filed

Sep 11, 8:00 PM ET

Accepted

Sep 12, 8:04 PM ET

Size

5.3 KB

Accession

0001567619-19-018220

Insider Transaction Report

Form 4
Period: 2019-09-10
Transactions
  • Award

    Director Stock Option (Right to Buy)

    2019-09-10+14,77714,777 total
    Exercise: $28.80Exp: 2029-09-09Common Stock (14,777 underlying)
Footnotes (1)
  • [F1]This option vests 100% and becomes exercisable on June 21, 2020, subject to reporting person's continued service through such vesting date.

Documents

1 file

Issuer

Stoke Therapeutics, Inc.

CIK 0001623526

Entity typeother

Related Parties

1
  • filerCIK 0001780081

Filing Metadata

Form type
4
Filed
Sep 11, 8:00 PM ET
Accepted
Sep 12, 8:04 PM ET
Size
5.3 KB